Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. IMVT
IMVT logo

IMVT News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IMVT News

Logos Global Management Increases Immunovant Stake to 1.375 Million Shares

1d agoFool

Logos Increases Immunovant Stake to $35 Million

1d agoNASDAQ.COM

S&P 500 Futures Rise in Pre-Market Session; Adobe and Ulta Beauty Underperform

3d agoBarron's

Alpine Global Management Reduces Immunovant Holdings

5d agoFool

S&P 500 Futures Rise in Pre-Market Trading; Circle Internet Group and Axon Enterprise Take the Lead

Feb 25 2026Barron's

Purcell & Lefkowitz Investigates Immunovant for Potential Fiduciary Breaches

Feb 17 2026PRnewswire

Immunovant Q3 Earnings Beat Expectations with Strong Cash Position

Feb 06 2026seekingalpha

Purcell & Lefkowitz Investigates Immunovant's Board Actions for Shareholder Breach

Jan 05 2026PRnewswire

IMVT Events

02/06 07:10
Immunovant Cash and Cash Equivalents Reach $994.5 Million
As of December 31, 2025, Immunovant's cash and cash equivalents totaled $994.5 million, providing runway for announced indications through the potential commercial launch of IMVT-1402 in GD

IMVT Monitor News

Immunovant Q3 Earnings Beat Expectations with Strong Cash Position

Feb 06 2026

Immunovant Inc raises $550 million for IMVT-1402 launch

Dec 11 2025

IMVT Earnings Analysis

No Data

No Data

People Also Watch